The antisense oligonucleotides market offers growth opportunities across diverse disease indications, with promising therapeutic developments for genetic, oncological, and neurological disorders. It ...

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate ...

ProteinQure announced new preclinical results today, demonstrating efficient delivery of small interfering RNA (siRNA) to the central nervous system (CNS) in non-human primates. Using intrathecal ...

PHILADELPHIA--(BUSINESS WIRE)-- Ceptur Therapeutics, Inc. (“Ceptur”), a biotechnology company focused on developing targeted oligonucleotide therapeutics based on U1 Adaptor technology, today ...

As the importance and prevalence of oligonucleotide therapeutics continue to grow, so does the need for robust characterization methodologies throughout drug development and production. Given the ...

Preclinical data shows use of megalin receptors for intracellular delivery of a ligand-siRNA conjugate to silence production of target mRNA in the kidney Megalin-binding genetic medicines are ...

“Beyond UniQure, the pipeline includes highly promising approaches that will ideally move the goal from merely managing ...

BOC Sciences has specialized in oligo materials and technologies for years. With a commitment to staying at the forefront of the industry, it has established a state-of-the-art Drug Delivery Platform ...

LIMERICK, Pa., Feb. 25, 2025 /PRNewswire/ -- Rockland Immunochemicals, Inc. is pleased to announce that Dr. David P. Chimento, Vice President of Research and ...

Delivering cutting-edge peer-reviewed research on using nucleic acids and related compounds to alter gene expression for therapeutic purposes. A new article in the peer-reviewed journal Nucleic Acid ...

The OTS is an open, nonprofit forum to foster research and development of oligonucleotide therapeutics. The mission is to bring together expertise across academia and industry-based oligonucleotide ...

Delivering Oligonucleotides with Specificity, Mitigating Off-Target Effects, and Improving Cellular Uptake to Target Undruggable Molecules. The Oligonucleotide-based Therapeutics Summit is uniting ...